Author details

Full Name

Dung-Fang Lee

Affiliation

ORCID

Career Start Year

2000

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36719996	Reprogramming Stars #10: Modeling Cancer with Cellular Reprogramming-An Interview with Dr. Dung-Fang Lee.		2023
37754095	Wearable Biosensor with Molecularly Imprinted Conductive Polymer Structure to Detect Lentivirus in Aerosol.		2023
36973285	Rewired m<sup>6</sup>A epitranscriptomic networks link mutant p53 to neoplastic transformation.	Nat Commun	2023
37205631	Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants.	Cancer Res	2023
37067901	Li-Fraumeni Syndrome-Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death.		2023
35037361	ZFP207 sustains pluripotency by coordinating OCT4 stability, alternative splicing and RNA export.	EMBO Reports	2022
35810559	METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.	eBioMedicine	2022
35728441	Generation of a homozygous knock-in human embryonic stem cell line expressing mEos4b-tagged CTR1.	Stem Cell Research	2022
35412907	Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies.	Proc Natl Acad Sci U S A	2022
36409720	Bcl11b and Atoh8 Coordinate Cellular Plasticity for Reprogramming and Transformation.	Cellular Reprogramming	2022
34831045	Cardiotoxicity of Antineoplastic Therapies and Applications of Induced Pluripotent Stem Cell-Derived Cardiomyocytes.	Cells	2021
34118566	Generation of a homozygous knock-in human embryonic stem cell line expressing SNAP-tagged SOD1.	Stem Cell Research	2021
34108665	RNA mA modification orchestrates a LINE-1-host interaction that facilitates retrotransposition and contributes to long gene vulnerability.	Cell Research	2021
33610014	Reprogramming and cancer.	Stem Cell Research	2021
34330033	Corrigendum to "Generation of a homozygous knock-in human embryonic stem cell line expressing SNAP-tagged SOD1" [Stem Cell Res. 54 (2021) 102415].	Stem Cell Research	2021
33816475	An Esrrb and Nanog Cell Fate Regulatory Module Controlled by Feed Forward Loop Interactions.	Front Cell Dev Biol	2021
34965247	Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome.	PLoS Genet	2021
34439241	The Function of the Mutant p53-R175H in Cancer.	Cancers	2021
33022533	Modeling of osteosarcoma with induced pluripotent stem cells.	Stem Cell Research	2020
31939194	Engineering Mutation Clones in Mammalian Cells with CRISPR/Cas9.	Methods in Molecular Biology	2020
33519915	LncRNA H19 Suppresses Osteosarcomagenesis by Regulating snoRNAs and DNA Repair Protein Complexes.	Frontiers in Genetics	2020
32585626	H19, a Long Non-coding RNA, Mediates Transcription Factors and Target Genes through Interference of MicroRNAs in Pan-Cancer.	Mol Ther Nucleic Acids	2020
32863940	Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue Sarcomas.	Theranostics	2020
30949405	Irradiation-induced dynamic changes of gene signatures reveal gain of metastatic ability in nasopharyngeal carcinoma.	American Journal of Cancer Research (discontinued)	2019
31704540	Generation of a genetically modified human embryonic stem cells expressing fluorescence tagged ATOX1.	Stem Cell Research	2019
31390555	Genomic Integrity Safeguards Self-Renewal in Embryonic Stem Cells.	Cell Rep	2019
29730572	Establishment of a human embryonic stem cell line with homozygous TP53 R248W mutant by TALEN mediated gene editing.	Stem Cell Research	2018
30312871	Generation of an induced pluripotent stem cell line from an individual with a heterozygous RECQL4 mutation.	Stem Cell Research	2018
30069853	Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.	Advances in Experimental Medicine and Biology	2018
30385632	Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism.	Proc Natl Acad Sci U S A	2018
30034933	Cancer in a dish: progress using stem cells as a platform for cancer research.	American Journal of Cancer Research (discontinued)	2018
29985349	Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells.	Journal of Visualized Experiments	2018
29530485	Genomic Profiling and Metabolic Homeostasis in Primary Liver Cancers.	Trends in Molecular Medicine	2018
29414603	A homozygous p53 R282W mutant human embryonic stem cell line generated using TALEN-mediated precise gene editing.	Stem Cell Research	2018
29414415	Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase.	Stem Cell Research	2018
27270422	MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.	Oncogene	2017
28735817	Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.	Trends in Molecular Medicine	2017
28648899	Transient HES5 Activity Instructs Mesodermal Cells toward a Cardiac Fate.	Stem Cell Reports	2017
28818333	Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.	Trends Pharmacol Sci	2017
28626837	The Histogenesis of Ewing Sarcoma.		2017
27722205	Modeling Cancer with Pluripotent Stem Cells.	Trends in Cancer	2016
26759241	AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation.	Cancer Res	2016
27519282	ZNF217/ZFP217 Meets Chromatin and RNA.	Trends Biochem Sci	2016
26198214	Distribution Analyzer, a methodology for identifying and clustering outlier conditions from single-cell distributions, and its application to a Nanog reporter RNAi screen.	BMC Bioinformatics	2015
25860607	Modeling familial cancer with induced pluripotent stem cells.	Cell	2015
25936917	Tex10 Coordinates Epigenetic Control of Super-Enhancer Activity in Pluripotency and Reprogramming.		2015
26526723	Coordination of m(6)A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming.	Cell Stem Cell	2015
26095607	Tbx3 Controls Dppa3 Levels and Exit from Pluripotency toward Mesoderm.	Stem Cell Reports	2015
26456833	Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia.	Cell Rep	2015
25240402	A genome-wide RNAi screen identifies opposing functions of Snai1 and Snai2 on the Nanog dependency in reprogramming.	Molecular Cell	2014